Eli Lilly Management Team

Lilly, Weight Loss Pill

From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Reuters on MSN · 14d

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs. Lilly said o

Business Insider · 2h

Eli Lilly (LLY) Stockpiles Weight Loss Pill Ahead of Regulatory Approval

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn’t stopped the

Quartz on MSN · 4h

Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the world. Now, the pharma giant wants to reinvest its success with weight-loss meds into tackling some of the world’s toughest health challenges.

Seeking Alpha on MSN · 6h

Lilly's next obesity drug serves up dramatic weight loss -- and side effects - report

Several individuals enrolled in a phase 3 trial for Eli Lilly's (NYSE:LLY) next-generation obesity drug, retatrutide, say that while they have seen incredible weight loss, it has also come with its share of notable side effects.

14don MSN

Eli Lilly Stock Rises After Profit, Outlook Top Expectations

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

8hon MSN

Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Hosted on MSN7d

Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

Nasdaq5d

Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » For years, Eli Lilly has been generating solid growth ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results